Literature DB >> 17507470

Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor.

Seii Ohka1, Hiroko Igarashi, Noriyo Nagata, Mai Sakai, Satoshi Koike, Tomonori Nochi, Hiroshi Kiyono, Akio Nomoto.   

Abstract

Poliovirus (PV) is easily transferred to humans orally; however, no rodent model for oral infections has been developed because of the alimentary tract's low sensitivity to the virus. Here we showed that PV is inactivated by the low pH of the gastric contents in mice. The addition of 3% NaHCO3 to the viral inoculum increased the titer of virus reaching the small intestine through the stomach after intragastric inoculation of PV. Transgenic mice (Tg) carrying the human PV receptor (hPVR/CD155) gene and lacking the alpha/beta interferon receptor (IFNAR) gene (hPVR-Tg/IfnarKO) were sensitive to the oral administration of PV with 3% NaHCO3, whereas hPVR-Tg expressing IFNAR were much less sensitive. The virus was detected in the epithelia of the small intestine and proliferated in the alimentary tract of hPVR-Tg/IfnarKO. By the ninth day after the administration of a virulent PV, the mice had died. These results suggest that IFNAR plays an important role in determining permissivity in the alimentary tract as well as the generation of virus-specific immune responses to PV via the oral route. Thus, hPVR-Tg/IfnarKO are considered to be the first oral infection model for PV, although levels of anti-PV antibodies were not elevated dramatically in serum and intestinal secretions of surviving mice when hPVR-Tg/IfnarKO were administered an attenuated PV.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507470      PMCID: PMC1951287          DOI: 10.1128/JVI.02675-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Pathogenesis of poliomyelitis; reappraisal in the light of new data.

Authors:  A B SABIN
Journal:  Science       Date:  1956-06-29       Impact factor: 47.728

2.  Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infection.

Authors:  J Chebath; P Benech; M Revel; M Vigneron
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

3.  Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.

Authors:  W X Yang; T Terasaki; K Shiroki; S Ohka; J Aoki; S Tanabe; T Nomura; E Terada; Y Sugiyama; A Nomoto
Journal:  Virology       Date:  1997-03-17       Impact factor: 3.616

4.  Isolation and characterization of defective-interfering particles of poliovirus Sabin 1 strain.

Authors:  S Kajigaya; H Arakawa; S Kuge; T Koi; N Imura; A Nomoto
Journal:  Virology       Date:  1985-04-30       Impact factor: 3.616

5.  A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.

Authors:  M Kohara; S Abe; T Komatsu; K Tago; M Arita; A Nomoto
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

Review 6.  [Tissue tropism and species specificity of poliovirus infection].

Authors:  J Aoki
Journal:  Tanpakushitsu Kakusan Koso       Date:  1994-09

7.  Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER.

Authors:  L Pelkmans; J Kartenbeck; A Helenius
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

8.  Transgenic mice susceptible to poliovirus.

Authors:  S Koike; C Taya; T Kurata; S Abe; I Ise; H Yonekawa; A Nomoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

9.  A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.

Authors:  Noriyo Nagata; Takuya Iwasaki; Yasushi Ami; Yuko Sato; Ikuyoshi Hatano; Ayako Harashima; Yuriko Suzaki; Takao Yoshii; Tsutomu Hashikawa; Tetsutaro Sata; Yoshinobu Horiuchi; Satoshi Koike; Takeshi Kurata; Akio Nomoto
Journal:  Virology       Date:  2004-03-30       Impact factor: 3.616

10.  Mechanism of injury-provoked poliomyelitis.

Authors:  M Gromeier; E Wimmer
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

View more
  42 in total

1.  Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous system.

Authors:  Lauren N Luethy; Andrea K Erickson; Palmy R Jesudhasan; Mine Ikizler; Terence S Dermody; Julie K Pfeiffer
Journal:  Virology       Date:  2015-10-16       Impact factor: 3.616

Review 2.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

3.  Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization.

Authors:  Jennifer L Konopka-Anstadt; Ray Campagnoli; Annelet Vincent; Jing Shaw; Ling Wei; Nhien T Wynn; Shane E Smithee; Erika Bujaki; Ming Te Yeh; Majid Laassri; Tatiana Zagorodnyaya; Amy J Weiner; Konstantin Chumakov; Raul Andino; Andrew Macadam; Olen Kew; Cara C Burns
Journal:  NPJ Vaccines       Date:  2020-03-20       Impact factor: 7.344

4.  A host-specific, temperature-sensitive translation defect determines the attenuation phenotype of a human rhinovirus/poliovirus chimera, PV1(RIPO).

Authors:  Nusrat Jahan; Eckard Wimmer; Steffen Mueller
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

Review 5.  Using Diverse Model Systems to Define Intestinal Epithelial Defenses to Enteric Viral Infections.

Authors:  Elisha Segrist; Sara Cherry
Journal:  Cell Host Microbe       Date:  2020-03-11       Impact factor: 21.023

6.  Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus.

Authors:  Christopher M Robinson; Palmy R Jesudhasan; Julie K Pfeiffer
Journal:  Cell Host Microbe       Date:  2014-01-15       Impact factor: 21.023

7.  Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells.

Authors:  Juliet M Morrison; Vincent R Racaniello
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response.

Authors:  Karen Z Lancaster; Julie K Pfeiffer
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

9.  Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor.

Authors:  Eva Calvo-Pinilla; Teresa Rodríguez-Calvo; Juan Anguita; Noemí Sevilla; Javier Ortego
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

10.  Type I interferon receptor-independent and -dependent host transcriptional responses to mouse hepatitis coronavirus infection in vivo.

Authors:  Matthijs Raaben; Marian J A Groot Koerkamp; Peter J M Rottier; Cornelis A M de Haan
Journal:  BMC Genomics       Date:  2009-08-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.